Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorAntoñanzas, J. (Javier)-
dc.creatorRodríguez-Garijo, N. (Nuria)-
dc.creatorEstenaga, Á. (Ángela)-
dc.creatorMorelló-Vicente, A. (Ana)-
dc.creatorEspaña, A. (Agustín)-
dc.creatorAguado, L. (Leyre)-
dc.date.accessioned2023-03-27T08:10:22Z-
dc.date.available2023-03-27T08:10:22Z-
dc.date.issued2022-
dc.identifier.citationAntoñanzas, J. (Javier); Rodríguez-Garijo, N. (Nuria); Estenaga, Á. (Ángela); et al. "Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review". Dermatologic Therapy. 35, 2022, e15709es_ES
dc.identifier.issn1529-8019-
dc.identifier.urihttps://hdl.handle.net/10171/65794-
dc.description.abstractThe appearance of morphea after vaccination has been reported to date as single and deep lesions that appear exactly at the site of the skin puncture. It was therefore postulated that the origin could be the trauma related to the injection. The aim of this article is to review the various hypotheses offered in the published literature about generalized morphea following vaccination. We present two cases of generalized morphea after COVID-19 vaccination and review the published literature on immune-related cutaneous reactions. As previously reported, antigenic crossreactivity between vaccine spike proteins and human tissues could cause certain immune-mediated diseases, including generalized morphea. Herein we report two cases of generalized morphea probably induced by the COVID-19 vaccine, given the temporal relationship with its administration. In summary, environmental factors such as vaccination against SARS-COV-2 could induce an immune system dysregulation, which would have an important role in the pathogenesis of morphea. We present two cases of generalized morphea probably induced by the COVID-19 vaccine, given the time elapsed between vaccination and the onset of the skin lesions.es_ES
dc.language.isospaes_ES
dc.publisherWileyes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectCOVIDes_ES
dc.subjectCross-reactivityes_ES
dc.subjectImmunorelatedes_ES
dc.subjectMorpheaes_ES
dc.subjectVaccinationes_ES
dc.titleGeneralized morphea following the COVID vaccine: A series of two patients and a bibliographic reviewes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.noteThis is an open access article under the terms of the Creative Commons Attribution Licensees_ES
dc.identifier.doi10.1111/dth.15709-
dadun.citation.publicationNameDermatologic Therapyes_ES
dadun.citation.startingPagee15709es_ES
dadun.citation.volume35es_ES
dc.identifier.pmid35811413-

Ficheros en este ítem:
Vista previa
Fichero
Generalized_morphea_following_the_COVID_vaccine_A_.pdf
Descripción
Tamaño
1.1 MB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.